查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1941195

持續正壓呼吸器市場 - 全球產業規模、佔有率、趨勢、機會及預測（按產品類型、類型、最終用戶、地區和競爭格局分類，2021-2031年）

Continuous Positive Airway Pressure, Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Type, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球持續性陽壓呼吸器（CPAP）設備市場預計將從 2025 年的 52.4 億美元成長到 2031 年的 78.7 億美元，複合年成長率為 7.01%。

這些設備作為治療性呼吸輔助裝置，透過面罩持續輸送加壓空氣，幫助阻塞型睡眠呼吸中止症中止症患者保持呼吸道暢通。該市場的成長主要受健康相關因素驅動，而非技術趨勢，例如睡眠障礙的增加、人口老化以及肥胖率上升，這些因素都在推動呼吸治療的需求。根據美國睡眠醫學會估計，到2024年，美國約有3,000萬成年人患有阻塞型睡眠呼吸中止症，這是一個龐大的患者群體，亟需此類醫療解決方案。

市場概覽
預測期 2027-2031
市場規模：2025年 52.4億美元
市場規模：2031年 78.7億美元
複合年成長率：2026-2031年 7.01%
成長最快的細分市場 自動的
最大的市場 北美洲

儘管市場需求強勁，但市場擴張常常受到許多挑戰的阻礙，包括患者依從性低和設備不耐受。身體不適和恐懼症常常導致治療中斷，限制了設備的長期使用和定期更換。診斷與治療依從性之間的脫節對產生收入構成重大障礙。根據美國國家睡眠基金會預測，到2025年，約有31%的睡眠呼吸中止症成年患者將無法獲得必要的治療，這表明在實現持續的市場滲透和治療成功方面仍存在諸多障礙。

市場促進因素

設備設計和連接方面的技術進步正在從根本上改變全球持續性陽壓呼吸器(CPAP) 設備市場，整合雲端生態系統可提高患者依從性並實現遠端監測。這些智慧解決方案有助於即時調整治療方案和自動數據追蹤，顯著降低傳統斷開式介面的高掉線率，同時簡化醫療服務提供者的臨床工作流程。根據 ResMed 於 2024 年 10 月發布的最終律師報告 (DEF 14A)，該公司報告稱其擁有 2,600 萬台可雲連接設備，展現了其數位化應用的廣泛規模。這項技術優勢正在推動商業性業績的成長，該公司於 2024 年 10 月發布的第一季財報顯示，營收成長了 11%，證實了市場對先進治療解決方案的強勁需求。

阻塞型睡眠呼吸中止症（OSA）盛行率的不斷上升是推動長期成長的關鍵因素，尤其是在全球仍有相當一部分人未被確診的情況下。儘管診斷途徑的改善和宣傳宣傳活動的發展正逐步將潛在需求轉化為實際用戶，但人口結構的變化，例如人口老化和肥胖率上升，導致需要呼吸支持的患者數量持續成長。根據瑞思邁（ResMed）於2024年8月發布的2024年度報告，預計全球將有9.36億人患有睡眠呼吸中止症，這代表著一個龐大的潛在患者群體，遠超目前的患病率。隨著公共衛生措施日益關注睡眠衛生，總盛行率與確診患者之間的差距不斷縮小，從而推動了呼吸器的持續普及。

市場挑戰

患者依從性低和對設備的耐受性差是嚴重阻礙全球持續陽壓呼吸器（CPAP）設備市場成長的挑戰。儘管治療效果高度依賴長期持續使用，但這些問題對市場擴張構成重大障礙，因為患者往往在確診後不久就因身體不適、面罩漏氣、恐懼症症等原因停止治療。高停藥率會減少面罩、軟管和過濾器等必需耗材的經常性收入，對市場產生負面影響，而這些耗材是製造商的主要利潤來源。

此外，患者治療依從性差限制了有效用戶群的成長，阻礙了引進週期，並降低了對替換設備的需求。確診患者數量與嚴格遵守治療方案的患者數量之間的脫節，造成了市場效率的顯著低下。美國胸腔科協會報告稱，到2024年，CPAP治療的整體依從率將約為50%。這項數據表明，由於依從性問題，近一半的潛在耗材和替換設備市場損失殆盡，儘管該行業服務的患者數量龐大，卻未能充分發揮其收入潛力。

市場趨勢

持續性呼吸道正壓通氣（CPAP）療法與消費級穿戴裝置和智慧家庭平台的融合，透過分散診斷流程並將未確診患者納入治療流程，推動了市場擴張。領先的科技公司正在將臨床級睡眠呼吸中止症檢測演算法整合到熱門智慧型手錶中，使這些消費性電子產品轉變為預篩檢工具，無需複雜的檢查室程序即可實現被動式、連續式的居家監測。這一趨勢惠及了大規模未確診患者，並鼓勵他們進行醫療諮詢。例如，三星電子在2024年2月的新聞稿中宣布，其Galaxy Watch的睡眠呼吸中止症功能已獲得美國食品藥物管理局（FDA）的全新醫療設備認證（De Novo），從而建立了一條直接面對消費者的管道，用於識別中度至重度阻塞型睡眠呼吸中止症。

同時，微接觸式面罩設計的進步正在改變患者介面系統介面，有效降低了因恐懼症和身體不適導致的高治療放棄率。製造商正逐步摒棄笨重的頭戴式裝置，轉而採用超輕便、微接觸式的鼻托和鼻枕，這些產品利用先進材料和自適應貼合技術，在不施加過大壓力的情況下提升氣密性。這種轉變著重美觀和舒適性，旨在提高使用者耐受性，維持長期依從性，並確保耗材的定期更換。費雪派克醫療保健公司（Fisher & Paykel Healthcare）也順應了這一趨勢，在其2024年5月發布的2024年度報告中，阻塞型睡眠呼吸中止症面罩的收入成長了21%，並將這一成功歸功於其新型微接觸式面罩平台在全球範圍內的日益普及。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

5. 全球持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品類型（CPAP 面罩、CPAP 加濕器、CPAP 馬達、其他）
    • 按類型（手動和自動）
    • 按最終使用者（醫院/診所、門診護理中心、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲持續陽壓呼吸器（CPAP）設備市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球持續陽壓呼吸器（CPAP）設備市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • ResMed Inc.
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare, LLC
  • BMC Medical Co., Ltd.
  • 3B Medical, Inc.
  • Somnetics International, Inc.
  • Apex Medical Corporation
  • Medtronic plc
  • LOwenstein Medical SE & Co. KG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 7465

The Global Continuous Positive Airway Pressure (CPAP) Devices Market is projected to expand from USD 5.24 Billion in 2025 to USD 7.87 Billion by 2031, registering a CAGR of 7.01%. These devices function as therapeutic respiratory aids, delivering a steady stream of pressurized air through a mask to maintain open airways for patients suffering from obstructive sleep apnea. The market is primarily propelled by health-related factors independent of technological trends, including the increasing prevalence of sleep disorders, an aging population, and rising obesity rates, all of which heighten the demand for respiratory interventions. According to the American Academy of Sleep Medicine, nearly 30 million adults in the United States were estimated to have obstructive sleep apnea in 2024, highlighting the substantial patient base necessitating these medical solutions.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.24 Billion
Market Size 2031USD 7.87 Billion
CAGR 2026-20317.01%
Fastest Growing SegmentAutomatic
Largest MarketNorth America

Despite strong demand, market expansion is frequently hindered by significant challenges related to patient non-compliance and device intolerance. Physical discomfort or claustrophobia often leads individuals to discontinue therapy, which limits the long-term adoption and scheduled replacement of these units. This disparity between diagnosis and adherence poses a critical obstacle to revenue generation. According to the National Sleep Foundation, approximately 31 percent of adults diagnosed with sleep apnea in 2025 were not receiving the necessary treatment, indicating a persistent barrier to achieving sustained market penetration and therapeutic success.

Market Driver

Technological advancements in device design and connectivity are fundamentally transforming the Global Continuous Positive Airway Pressure (CPAP) Devices Market by integrating cloud-based ecosystems that improve patient adherence and enable remote monitoring. These smart solutions facilitate real-time therapy adjustments and automated data tracking, which significantly lowers the high drop-out rates associated with traditional, non-connected interfaces while streamlining clinical workflows for healthcare providers. According to ResMed's 'Definitive Proxy Statement (DEF 14A)' from October 2024, the company reported a network of 26 million cloud-connectable devices, illustrating the massive scale of digital adoption. This technological leverage drives commercial performance, as evidenced by ResMed's 'First Quarter 2025 Earnings Press Release' in October 2024, which noted an 11 percent increase in revenue, underscoring the strong demand for advanced therapeutic solutions.

The increasing prevalence of Obstructive Sleep Apnea (OSA) acts as a primary driver for long-term expansion, especially given that a large segment of the global population remains undiagnosed. Enhanced diagnostic accessibility and awareness campaigns are gradually converting this latent demand into active users, while demographic shifts such as aging populations and rising obesity rates create a continuous influx of patients needing respiratory support. According to ResMed's '2024 Annual Report' from August 2024, an estimated 936 million people globally live with sleep apnea, representing a massive addressable patient pool exceeding current penetration levels. As public health initiatives focus on sleep hygiene, the gap between the total prevalence and the diagnosed population continues to close, fueling sustained device adoption.

Market Challenge

Patient non-compliance and device intolerance represent the challenging factors that significantly impede the growth of the Global Continuous Positive Airway Pressure (CPAP) Devices Market. These issues create substantial barriers to expansion because therapeutic effectiveness depends heavily on consistent, long-term usage, yet patients often abandon treatment shortly after diagnosis due to physical discomfort, mask leaks, or claustrophobia. High rates of therapy discontinuation negatively impact the market by diminishing the recurring revenue streams derived from essential consumables, such as masks, hoses, and filters, which constitute a major source of ongoing profit for manufacturers.

Furthermore, the inability to retain patients on therapy restricts the growth of the active user base, stalling the adoption cycle and lowering the demand for replacement devices. The discrepancy between the number of diagnosed patients and those who strictly adhere to the treatment regimen results in significant market inefficiency. According to the American Thoracic Society, overall compliance rates for CPAP therapy were reported to be approximately 50 percent in 2024. This statistic indicates that nearly half of the potential market for consumables and replacement units is lost to adherence issues, preventing the industry from realizing its full revenue potential despite the existence of a large addressable patient population.

Market Trends

The convergence of CPAP therapy with consumer wearables and smart home platforms is driving market expansion by decentralizing diagnostic pathways and guiding undiagnosed patients into treatment pipelines. Tech giants are embedding clinical-grade sleep apnea detection algorithms into popular smartwatches, turning consumer gadgets into preliminary screening tools that bypass complex laboratory procedures and enable passive, longitudinal home monitoring. This trend addresses the large undiagnosed patient pool by triggering medical consultations, as seen when Samsung Electronics announced in a February 2024 press release that it received De Novo authorization from the U.S. Food and Drug Administration for the sleep apnea feature on its Galaxy Watch, establishing a direct consumer channel for identifying moderate to severe obstructive sleep apnea.

Simultaneously, advancements in minimal-contact mask designs are revolutionizing the patient interface landscape to combat high therapy termination rates resulting from claustrophobia and physical discomfort. Manufacturers are moving away from bulky headgear in favor of ultra-lightweight, minimal-contact nasal cradles and pillows that employ advanced materials and auto-adjusting fit technologies to improve seal integrity without applying aggressive pressure. This shift focuses on aesthetics and comfort to improve user tolerance and sustain long-term compliance, ensuring regular replacement of consumables. Validating this trend, Fisher & Paykel Healthcare reported a 21 percent growth in obstructive sleep apnea mask revenue in their 'Annual Report 2024' from May 2024, attributing this success to the strong global adoption of their new minimalist mask platforms.

Key Market Players

  • ResMed Inc.
  • Koninklijke Philips N.V.
  • Fisher & Paykel Healthcare Limited
  • Drive DeVilbiss Healthcare, LLC
  • BMC Medical Co., Ltd.
  • 3B Medical, Inc.
  • Somnetics International, Inc.
  • Apex Medical Corporation
  • Medtronic plc
  • LOwenstein Medical SE & Co. KG

Report Scope

In this report, the Global Continuous Positive Airway Pressure (CPAP) Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Continuous Positive Airway Pressure (CPAP) Devices Market, By Product Type

  • CPAP Masks
  • CPAP Humidifier
  • CPAP Motors
  • Others

Continuous Positive Airway Pressure (CPAP) Devices Market, By Type

  • Manual
  • Automatic

Continuous Positive Airway Pressure (CPAP) Devices Market, By End User

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Continuous Positive Airway Pressure (CPAP) Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Continuous Positive Airway Pressure (CPAP) Devices Market.

Available Customizations:

Global Continuous Positive Airway Pressure (CPAP) Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (CPAP Masks, CPAP Humidifier, CPAP Motors, Others)
    • 5.2.2. By Type (Manual v/s Automatic)
    • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Type
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By End User

7. Europe Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Type
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By End User
    • 7.3.2. France Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By End User

8. Asia Pacific Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Type
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By End User
    • 8.3.2. India Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By End User

9. Middle East & Africa Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Type
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By End User

10. South America Continuous Positive Airway Pressure (CPAP) Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Type
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Continuous Positive Airway Pressure (CPAP) Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Continuous Positive Airway Pressure (CPAP) Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. ResMed Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Koninklijke Philips N.V.
  • 15.3. Fisher & Paykel Healthcare Limited
  • 15.4. Drive DeVilbiss Healthcare, LLC
  • 15.5. BMC Medical Co., Ltd.
  • 15.6. 3B Medical, Inc.
  • 15.7. Somnetics International, Inc.
  • 15.8. Apex Medical Corporation
  • 15.9. Medtronic plc
  • 15.10. LOwenstein Medical SE & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer